RBBP8 and breast cancer: As shown in Figure 4B, the control Ctip+/+,co/+/p53co/+/Wapcre/+ females developed mammary tumors with an average latency of 331 days, but tumor formation was again severely reduced by co-inactivation of Ctip (Figure 4B).